Jan J Bandolik

4PUBLICATIONS
5CO-AUTHORS
Inorganic green chemistryMolecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 02, 2021
New Acetophenones and Chromenes from the Leaves of Melicope barbigera A. Gray.

Kim-Thao Le, Jan J Bandolik, Matthias U Kassack

|Nov 10, 2020
Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors.

Ana J Rodrigues Moita, Jan J Bandolik, Finn K Hansen

|Aug 12, 2020
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs).

Laura Sinatra, Jan J Bandolik, Martin Roatsch

|Jun 26, 2019
Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.

Jan J Bandolik, Alexandra Hamacher, Christian Schrenk

Pageof 1

Frequent Collaborators

2 joint publications

Matthias U Kassack

1 joint publications

Laura Sinatra

1 joint publications

Finn K Hansen

1 joint publications

Thomas Kurz